Pre-Symptomatic Memory Impairment Herman Buschke, MD Einstein Aging Study (NIA AG-03949) Department of Neurology Albert Einstein College of Medicine

Slides:



Advertisements
Similar presentations
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Advertisements

Speed of processing, the missing measure in early detection of MCI? Ruth O’Hara March 13 th 2001 Yogesh Shah.
Department of Neurology, Mayo Clinic Arizona
Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.
MemTrax (Computerized Memory Screen) American Association of Geriatric Psychiatry (AAGP) March 2, 2007 J. Wesson Ashford, M.D., Ph.D. Stanford / VA Aging.
PRACTICE PARAMETER: RISK OF DRIVING AND ALZHEIMER ’ S DISEASE (AN EVIDENCE-BASED REVIEW) Richard M. Dubinsky, MD; Anthony C. Stein, PhD; and Kelly Lyons,
Estimating Rats’ Working Memory Capacity in an Object Recognition Foraging Task Jerome Cohen, Xue Han, Anca Matei, Vara Parameswaran Department of Psychology,
Screening for Alzheimer’s disease Herman Buschke, MD Einstein Aging Study (NIA AG-03949) Department of Neurology Albert Einstein College of Medicine.
Ontologies for the Study of Neurological Disease Mark Jensen ICBO 2012—Workshop on Mental Functioning July 22, Graz, Austria.
Dementia and Aging Steven Huege, M.D Assistant Professor of Clinical Psychiatry Perelman School of Medicine at the University of Pennsylvania.
Tony WAEGEMANS, MD UCB Pharma, Belgium. TW/ll/ Washington/MCI 2 MCI as implemented in our study MCI is a very early stage of dementia with as main.
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
CSF sulfatide is decreased in individuals with incipient dementia Xianlin Han, PhD, Anne M. Fagan, PhD, Hua Cheng, MS, John C. Morris, MD, Chengjie Xiong,
Signed Paired Associates Test (SPAT). SPAT Structure Similar to WMS “paired associates” subtest 14 sign pairs – 7 easy & 7 hard Based on sign associate.
Mary Ganguli’s Slides March 13 th Meeting. Mild Cognitive Impairment A View from the Trenches.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Mild Cognitive Impairment
ACT on Alzheimer’s Disease Curriculum Module VI: Screening.
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
Nikki Jandt Denise Halbach Tearanie VanBoxel Life Cycle Nutrition
Research Overview - Matthew Brehmer Jan 12, 2011 IDRG/MUX Forum.
Pr Bruno Dubois Head of the Dementia Research Center (IMMA)
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
Barbara A. Wilson, Eve Greenfield, Linda Clare, Alan Baddeley, Janet Cockburn, Peter Watson, Robyn Tate, Sara Sopena, Rory Nannery & John Crawford (2008)
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
CLINICAL REVIEW: Driving and dementia David A Breen, David P Breen, John W Moore, Patricia A Breen, Desmond O’Neill BMJ 2007;334:
Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.
Epidemiology of Dementia: the MoVIES Project Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh Initially funded by NIA under.
+ Treatment of Aphasia Week 12 April 1 st, Review Involvement of semantic and phonological stages in naming. Differentiating features of naming.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
MEMORY ASSESSMENT in the LAB vs. the CLINIC
Advancing research diagnostic criteria for Alzheimer's disease: implications for drug development and public health management Jean François Dartigues.
Amnesia and Alzheimer’s Kim Hyun-woo. Place photo here.
Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director.
MULTIPLE MEMORY SYSTEM IN HUMANS
The Influence of Feature Type, Feature Structure and Psycholinguistic Parameters on the Naming Performance of Semantic Dementia and Alzheimer’s Patients.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Classification of Patients with Mild Cognitive Impairment vs. Normal Controls based on Experimental and Conventional Standardized Measures of Processing.
MCI Conversion to Dementia: Clinic and Community-Based Studies
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Clinical, cognitive and genetic predictors of conversion from amnestic mild cognitive impairment to Alzheimer’s disease in Chinese older adults (Chu LW,
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
A FMRI Episodic Memory Study A longitudinal protocol in 31 patients presenting with early memory complain F. Gelbert C. Belin, A.M. Ergis, C. Moroni, C.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Mild Cognitive Impairment (MCI) Screening Tools for Primary Care Providers Jamila Hussain, PGY-3 Faculty Development Cook County-Loyola-Provident Family.
Cognitive Testing, Statistics and Dementia Ralph J. Kiernan Ph.D. 14 th May 2013.
Chapter 7 Memory. Objectives 7.1 Overview: What Is Memory? Explain how human memory differs from an objective video recording of events. 7.2 Constructing.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Volume 3, Issue 4, Pages (November 2017)
The BrainHealthRegistry
Joe Verghese, MBBS, MS. Translating Insights from
Mayo Clinic College of Medicine
Cognitive Biomarker of MS
Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire  Roos J.
Cognitive Neuroscience and Dementia
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin  Eva Carro, Fernando Bartolomé, Félix Bermejo-Pareja,
PPMI in the Medical Literature
Designed for individuals ages 16 and older.
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Early Dementia Distinguishing AD From MCI
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Late Adulthood: Cognitive Development
New Face-Name Paradigm for Patients with Mild Alzheimer’s Disease
Figure 2 A case of early-onset PSD
Massimo S. Fiandaca, Mark E. Mapstone, Amrita K. Cheema, Howard J
Box plot showing the distribution of the TYM-MCI score for patients with SMC and aMCI/AD. aMCI/AD, amnestic mild cognitive impairment or Alzheimer’s disease;
Presentation transcript:

Pre-Symptomatic Memory Impairment Herman Buschke, MD Einstein Aging Study (NIA AG-03949) Department of Neurology Albert Einstein College of Medicine Semmelweis University Budapest July 20, 2009

Screening for Pre-Symptomatic AD need to detect memory impairment when memory is declining but is still in normal range trials of early treatment early treatment to preserve cognition prevention trials …………….

Memory Impairment = Low Recall ?  cannot detect early memory impairment ( when declining memory is still in normal range)  because impairment is defined by low recall, when memory impairment is severe and late

Memory Capacity Test (MCT)  the MCT is intended to detect early memory impairment (when declining memory is still within normal limits)  using controlled learning and cued recall to induce encoding specificity and maximum retrieval  to evaluate associative encoding shown by binding a second item to each cue

Overview In a sample of community-dwelling older adults, all aged with AD, 40% of the aged with aMCI, 15% of non-demented aged with normal 1st list recall, had low cognitive binding relative to their own 1st list recall. Those with low binding have lower mental status and cognitive scores and slower recall. Sperling and Rentz et al have found that MCT scores are correlated with PiB retention and can distinguish the PiB positive.

Controlled Learning * * Identify each item when given its Category Cue

Controlled Learning  shows that items are associated with their category cues  shows that individuals can produce items elicited by their category cues  induces binding of items to specific cues  assures attention to and equal processing of all items  induces deep semantic processing  induces all individuals to do the same processing  shows that the required processing was done  ensures that decreased recall is due to impaired memory  induces “Encoding Specificity” to maximize recall

Category Cued Recall * * Recall each item when given its Category Cue

Encoding Specificity “specific encoding operations performed on what is perceived determine what is stored and what is stored determines what retrieval cues are effective in providing access to what is stored” Tulving & Thomson, Psych Review, 1973, page 369 Encoding and retrieval must be coordinated.

Encoding Specificity retrieval depends on cues effectiveness of cues depends on what was stored what was stored depends on encoding operations performed on what was perceived

Encoding Specificity to maximize retrieval, acquisition & retrieval must be coordinated by controlled learning & retrieval: retrieval cues must also be present at encoding

Cued Recall superior to Free Recall  assures attention to and testing of all items  number of items recalled measures memory accurately  controls order of recall: all subjects recall all items in the same order equalizes the interval between learning and recall obviates need for interference before recall prevents output order interference  facilitates measurement of retrieval speed  realizes Encoding Specificity to maximize recall & recall speed

Controlled Learning + Controlled Recall coordinates encoding and retrieval by using the same cues for learning and retrieval induces encoding specificity which improves retrieval and discrimination of dementia * because retrieval by aged without dementia is improved more than retrieval by aged with dementia * Buschke, Sliwinski, Kuslansky, Lipton, Neurology, 1997

Recall with and without Encoding Specificity * * Buschke, Sliwinski, Kuslansky, Lipton, Neurology, 1997 * Effect size = mean difference / pooled sd

Memory Capacity Test (MCT) Using Controlled Learning and Cued Recall 1.Learn 1st list of 16 items, each from a different category 2.Cued Recall 1st list 3. Learn 2nd list of 16 new items from the same categories 4.Cued Recall 2nd list 5.Cued Recall Both Items from Both Lists 6.Free Recall Both Lists

MCT87 F 12yr FR=5 B=6LIST 1LIST 2BOTH 1 & 2 CATEGORY CUELearnRecallLearnRecallList 1List 2 1Reading MaterialNovelTextbook 2StateFlorida+Colorado+ 3Female NameLaura+Susan++ 4Gardener’s ToolsHoe+Rake++ + 5Human DwellingShack+Mansion+ 6CrimeRobbery+Arson++ 7ClergyPastor+Rabbi++ 8Earth FormationVolcano+Canyon+ 9Kind of DanceFoxtrot+Waltz++ 10FlowerTulip+Carnation+ 11Military TitleCaptain+General+ 12DistanceMile+Inch+ 13DiseasePlague+Measles Elective OfficeGovernor+Mayor HerbDill+Parsley+ 16ShipTugboatSubmarine + + Cued Recall147113

Study 1 ROC AUCSpecificitySensitivity List 1 + Both 2 tru List 1 alone Free Recall

Low vs. High Binding

Incident Binding Impairment

Low 2nd item recall with the same cue: Acquired Not due to difficulty Precedes impairment of 1st List recall

Retrieval Speed Retrieval speed was measured in milliseconds from onset of each cue to onset of item recall of a 16-item list with one item from each of 16 categories; each category cue was presented to elicit retrieval of the to-be-remembered item from that category, using Controlled Learning and Cued Recall, with the same cues in learning and recall, for Encoding Specificity to maximize recall and retrieval speed; Maximum recall and retrieval speed are needed to detect impairment, because impairment means that maximum performance is decreased;

Retrieval Speed MCT <= 50% (n =76) MCT > 50% (n =298) MeanstdMeanstd Age Education Gender Free Recall “MCT” = recall of both items from same cue as % of list 1 recall

Speed and Recall Correlation

MCT & aMCI Recall Time (msec) MCT <= 50% n = 76 not MCT > 50% n =298 aMCI <= 24 n = not aMCI >24 n=

aMCI Effect Size (not MCT > 50 %) aMCI Free Recall <= 24 not aMCI Free Recall > 24 NRTSDNRTSDP Effect Size * * Cohen’s d effect size: 95% Confidence = – 0.971

MCT Effect Size * MCT <= 50 % not MCT > 50 % NRTSDNRTSDP Effect Size * * Cohen’s d effect size: 95% Confidence = – 1.02

Decreased Binding = Early Memory Impairment FACE VALIDITY: low 2nd list recall with the same cues ACCURACY: good sensitivity and specificity DISTRIBUTION: 100 % of aged with dementia (AD) have low 2 nd item recall COGNITIVE DEFICITS: lower mental status and cognitive scores INCIDENT IMPAIRMENT: when 1st list recall still within normal limits RETRIEVAL SPEED: slower recall BIOVALIDATION: MCT correlated with PiB retention, discriminates PiB+ 50 % of aged with MCI have low 2nd item recall 15 % of non-demented aged have low 2nd item recall

MCT Summary  identifies early pre-symptomatic memory impairment by low 2 nd item recall relative to 1st list recall when declining memory is still within normal limits  detects early pre-symptomatic memory impairment in 15% of aged who still have normal 1 st list recall  detecting early pre-symptomatic memory impairment provides the necessary basis for early treatment trials, early treatment to preserve cognitive function, and prevention trials

Disclosure Albert Einstein College of Medicine owns US Patent 7,314,444 for “Memory Assessment by Retrieval Speed” Albert Einstein College of Medicine has filed a patent application for the Memory Capacity Test Albert Einstein College of Medicine makes these tests available as a service to the research community but licenses the tests for commercial use.

Thank You

References for Controlled Learning & Cued Recall Amnestic syndrome of the medial temporal type identifies prodromal AD. Neurology, 2007; 69: M. Sarazin, C. Berr, J. De Rotrou, C. Fabrigoule, F. Pasquier, S. Legrain, B. Michel, Puel, M. Volteau, J. Touchon, M. Verny and B. Dubois “Results: A total of 59 subjects converted to AD dementia. The most sensitive and specific test for diagnosis of prodromal AD was the FCSRT.” “ Conclusions: The amnestic syndrome of the medial temporal type, defined by the Free and Cued Selective Reminding Test, is able to distinguish patients at an early stage of Alzheimer disease from mild cognitive impairment non-converters.”

References for Controlled Learning & Cued Recall Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurology, 2007; 6: Bruno Dubois, Howard Feldman, Claudia Jacova, Steven DeKosky, Pascale Barberger-Gateau, Jeffrey Cummings, André Delacourte, Douglas Galasko, Serge Gauthier, Gregory Jicha, Kenichi Meguro, John O’Brien, Florence Pasquier, Philippe Robert, Martin Rossor, Steven Salloway, Yaakov Stern, Pieter Visser, Philip Scheltens “The accurate diagnosis of the episodic memory deficit of AD can be improved by use of test paradigms that provide encoding specificity. …Coordinated encoding and retrieval paradigms of this type include the free and cued recall test or similar cued recall paradigms... Reduced benefit from cueing at recall reliably identifies prodromal AD.” (p. 738)